DV
Dividend Vision

IOVA — Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. (IOVA)

Total return is -93.7% over the past 15.8 years, 865.1 points behind SPY at 771.4%. Its deepest 1-year drawdown was 39.0%.

IOVA is an equity fund that holds shares in Iovance Biotherapeutics, a biopharmaceutical company focused on cell therapy development. The fund does not currently pay distributions and lacks a meaningful yield profile, with no expense ratio or asset under management data readily available. This fund structure appeals primarily to growth-oriented investors seeking exposure to the biotechnology sector rather than income-focused dividend investors.

IOVA key facts

Asset type
Stock
Asset class
Equity
Inception date
10/15/2010
Distribution frequency
None
Last close
$6.98
Market cap
$3,161,740,544
Average volume
17439900.0
Beta
0.701
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.74